Romosozumab and Denosumab Combination Therapy: Clinical Trials

1 trial of Romosozumab and Denosumab Combination Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow Romosozumab and Denosumab Combination Therapy: new trials by email Literature Review of Romosozumab and Denosumab Combination Therapy trials Research Report on Romosozumab and Denosumab Combination Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures
Romosozumab and Denosumab Combination Therapy, Romosozumab Prefilled Syringe [Evenity], Denosumab (Prolia) - Osteoporosis in Post-menopausal Women
Phase 4Not yet recruitingMarmara University602025-01-152024-12-27

Conditions studied

Osteoporosis (1)

Sponsors

Marmara University (1)

Countries

Turkey (Türkiye) (1)

Top investigators

Canan Sanal, Associate Profesor (1)